{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:32:08Z","timestamp":1760783528349,"version":"3.37.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HHSN275201000018C"],"award-info":[{"award-number":["HHSN275201000018C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The management options for the autosomal recessive neurodegenerative disorder spinal muscular atrophy (SMA) are evolving; however, their efficacy may require presymptom diagnosis and continuous treatment. To identify presymptomatic SMA patients, we created a DNA-based newborn screening assay to identify the homozygous deletions of the SMN1 (survival of motor neuron 1, telomeric) gene observed in 95%\u201398% of affected patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>We developed primers that amplify a 52-bp PCR product from homologous regions in the SMN1 and SMN2 (survival of motor neuron 2, centromeric) genes that flank a divergent site at site c.840. Post-PCR high-resolution melt profiling assessed the amplification product, and we used a unique means of melt calibration to normalize profiles. Samples that we had previously characterized for the numbers of SMN1 and SMN2 copies established genotypes associated with particular profiles. The system was evaluated with approximately 1000 purified DNA samples, 100 self-created dried blood spots, and &amp;gt;1200 dried blood spots from newborn screening tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Homozygous deletion of SMN1 exon 7 produced a distinctive melt profile that identified SMA patients. Samples with different numbers of SMN1 and SMN2 copies were resolved by their profiles. All samples with homozygous deletions were unambiguously recognized, and no normal sample was misidentified as a positive.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>This assay has characteristics suitable for population-based screening. A reliable screening test will facilitate the identification of an SMA-affected cohort to receive early intervention to maximize the benefit from treatment. A prospective screening trial will allow the efficacy of treatment options to be assessed, which may justify the inclusion of SMA as a target for population screening.<\/jats:p><\/jats:sec>","DOI":"10.1373\/clinchem.2012.183038","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T00:57:19Z","timestamp":1334019439000},"page":"1033-1039","source":"Crossref","is-referenced-by-count":31,"title":["Newborn Screening for Spinal Muscular Atrophy by Calibrated Short-Amplicon Melt Profiling"],"prefix":"10.1093","volume":"58","author":[{"given":"Steven F","family":"Dobrowolski","sequence":"first","affiliation":[{"name":"Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha T","family":"Pham","sequence":"first","affiliation":[{"name":"ARUP Laboratories, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Pouch Downes","sequence":"first","affiliation":[{"name":"Michigan Department of Community Health, Lansing, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W","family":"Prior","sequence":"first","affiliation":[{"name":"Department of Pathology, Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin W","family":"Naylor","sequence":"first","affiliation":[{"name":"BioChem Genetics LLC, Isle of Palms, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy J","family":"Swoboda","sequence":"first","affiliation":[{"name":"Departments of Neurology and"},{"name":"Pediatrics, University of Utah School of Medicine, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,6,1]]},"reference":[{"key":"2020022705134315900_B1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1373\/49.7.1227","article-title":"Mass spectrometry-based diagnostics: the upcoming revolution in disease detection has already arrived","volume":"49","author":"Chace","year":"2003","journal-title":"Clin Chem"},{"key":"2020022705134315900_B2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1373\/clinchem.2003.022178","article-title":"Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns","volume":"49","author":"Chace","year":"2003","journal-title":"Clin Chem"},{"key":"2020022705134315900_B3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1373\/clinchem.2010.144915","article-title":"High-throughput multiplexed T-cell\u2013receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening","volume":"56","author":"Gerstel-Thompson","year":"2010","journal-title":"Clin Chem"},{"key":"2020022705134315900_B4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Arch Neurol"},{"key":"2020022705134315900_B5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/344540a0","article-title":"Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2\u201313.3","volume":"344","author":"Brzustowicz","year":"1990","journal-title":"Nature"},{"key":"2020022705134315900_B6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"2020022705134315900_B7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"Mailman","year":"2002","journal-title":"Genet Med"},{"key":"2020022705134315900_B8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498853","article-title":"Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2","volume":"78","author":"Cartegni","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2020022705134315900_B9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat Genet"},{"key":"2020022705134315900_B10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"2020022705134315900_B11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","article-title":"Valproate may improve strength and function in patients with type III\/IV spinal muscular atrophy","volume":"67","author":"Weihl","year":"2006","journal-title":"Neurology"},{"key":"2020022705134315900_B12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1476-5381.2012.01829.x","article-title":"Triptolide increases transcript and protein levels of survival motor neurons in human SMA fibroblasts and improves survival in SMA-like mice","volume":"166","author":"Hsu","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2020022705134315900_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","article-title":"Spinal muscular atrophy: a clinical and research update","volume":"46","author":"Markowitz","year":"2012","journal-title":"Pediatr Neurol"},{"key":"2020022705134315900_B14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11910-011-0240-9","article-title":"New therapeutic approaches to spinal muscular atrophy","volume":"12","author":"Lewelt","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2020022705134315900_B15","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1172\/JCI58752","article-title":"Of SMN in mice and men: a therapeutic opportunity","volume":"121","author":"Swoboda","year":"2011","journal-title":"J Clin Invest"},{"key":"2020022705134315900_B16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/ajmg.a.33519","article-title":"Seize the day: newborn screening for SMA","volume":"152A","author":"Swoboda","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2020022705134315900_B17","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.5858\/1999-123-1154-OOAADP","article-title":"Optimization of an automated DNA purification protocol for neonatal screening","volume":"123","author":"Heath","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"2020022705134315900_B18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/humu.20558","article-title":"Streamlined assessment of gene variants by high resolution melt profiling utilizing the ornithine transcarbamylase gene as a model system","volume":"28","author":"Dobrowolski","year":"2007","journal-title":"Hum Mutat"},{"key":"2020022705134315900_B19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymgme.2007.03.010","article-title":"Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles","volume":"91","author":"Dobrowolski","year":"2007","journal-title":"Mol Genet Metab"},{"key":"2020022705134315900_B20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/humu.21003","article-title":"Identifying sequence variants in the human mitochondrial genome using high-resolution melt (HRM) profiling","volume":"30","author":"Dobrowolski","year":"2009","journal-title":"Hum Mutat"},{"key":"2020022705134315900_B21","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1093\/nar\/gkn204","article-title":"Base-pair neutral homozygotes can be discriminated by calibrated high-resolution melting of small amplicons","volume":"36","author":"Gundry","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2020022705134315900_B22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2","volume":"130A","author":"Prior","year":"2004","journal-title":"Am J Med Genet A"},{"key":"2020022705134315900_B23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.21350","article-title":"An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy","volume":"40","author":"Elsheikh","year":"2009","journal-title":"Muscle Nerve"},{"key":"2020022705134315900_B24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","article-title":"Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene","volume":"125","author":"Alias","year":"2009","journal-title":"Hum Genet"},{"key":"2020022705134315900_B25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.braindev.2008.08.012","article-title":"Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy","volume":"31","author":"Watihayati","year":"2009","journal-title":"Brain Dev"},{"key":"2020022705134315900_B26","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ejhg.2008.41","article-title":"Unaffected patients with a homozygous absence of the SMN1 gene","volume":"16","author":"Jedrzejowska","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"2020022705134315900_B27","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1373\/clinchem.2007.092312","article-title":"Assessment of liquid microbead arrays for the screening of newborns for spinal muscular atrophy","volume":"53","author":"Pyatt","year":"2007","journal-title":"Clin Chem"},{"key":"2020022705134315900_B28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.gim.0000227970.60450.b2","article-title":"A feasibility study for the newborn screening of spinal muscular atrophy","volume":"8","author":"Pyatt","year":"2006","journal-title":"Genet Med"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/58\/6\/1033\/32657902\/clinchem1033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/58\/6\/1033\/32657902\/clinchem1033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T14:29:56Z","timestamp":1641997796000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/58\/6\/1033\/5620823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,1]]},"published-print":{"date-parts":[[2012,6,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2012.183038","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"type":"print","value":"0009-9147"},{"type":"electronic","value":"1530-8561"}],"subject":[],"published-other":{"date-parts":[[2012,6,1]]},"published":{"date-parts":[[2012,6,1]]}}}